BSE announces demat auction settlement for scrips with delivery shortages across multiple companies including significant quantities of Tilak Ventures Limited.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting 87 scrips with delivery shortages. Notable for exceptionally high quantity of Tilak Ventures Limited (5,990,413 shares) and several other scrips with substantial quantities. Medium impact as it indicates settlement failures requiring auction mechanism.
BSE announces demat auction for settlement number 797 involving 85 scrips across various companies with specified quantities for auction.
Impact
Medium
Severity
Medium
Justification
Settlement auction affects 85 scrips with varying quantities including one high-volume scrip (Tilak Ventures with 5.99 million shares). This is a routine market operation but with significant scope across multiple companies.
BSE circular listing 138 companies eligible for Group A classification, including major corporations across sectors such as Adani Group entities, banking, pharmaceuticals, automotive, and industrial companies.
Impact
Medium
Severity
Medium
Justification
This circular provides the official list of 138 companies eligible for Group A classification on BSE, affecting trading parameters and investor perception. Group A typically denotes the most liquid and actively traded securities, impacting trading limits, margins, and settlement processes for these companies.
BSE announces the list of 139+ companies eligible for trading in Group A segment, representing high liquidity and quality securities including major blue-chip stocks across various sectors.
Impact
High
Severity
Medium
Justification
Group A classification affects trading parameters, margin requirements, and investor perception for 139+ major securities including all key blue-chip stocks. This classification determines liquidity standards and trading privileges on BSE.
NSE notifies the listing of further equity shares for eight companies including Axis Bank, Biocon, CG Power, IndoStar Capital, Lodha Developers, Mastek, Sun Pharmaceutical Industries, and Tube Investments of India, effective January 12, 2026.
Impact
Low
Severity
Low
Justification
Routine listing notification for further issues through ESOP and preferential allotments. Market lot remains 1 for all securities. No significant operational or trading impact.
Listing of 17,12,79,553 equity shares of Biocon Limited issued at Rs. 405.78 on preferential basis pursuant to share swap, effective January 12, 2026.
Impact
Medium
Severity
Medium
Justification
Material listing of significant number of equity shares (171.28 million) on preferential basis with lock-in period, impacting Biocon's capital structure
Biocon Limited lists 17,12,79,553 new equity shares issued at Rs. 405.78 per share through preferential allotment via share swap, with trading commencing January 12, 2026.
Impact
High
Severity
Medium
Justification
Major capital event involving over 171 million new shares representing significant dilution; large-scale preferential allotment to non-promoters with 6-month lock-in period
NSE admits commercial paper securities of Biocon Limited and Kotak Securities Limited to trading on the debt market segment effective January 05, 2026.
Impact
Low
Severity
Low
Justification
Routine listing notification for commercial paper securities with no broader market implications or regulatory changes
BSE demat auction settlement for delivery shortages across 130 scrips with quantities ranging from 1 to 50,000 shares.
Impact
Low
Severity
Low
Justification
Routine demat auction for settlement of delivery shortages; standard market operations procedure affecting specific scrips with limited market-wide impact